Hyosung Chemical Reviewes Withdrawal of Domestic Nylon Film Production Line

Reporter Kim Jisun / approved : 2023-07-21 01:52:41
  • -
  • +
  • 인쇄
 

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] It has been confirmed that Hyosung Chemical is considering withdrawing its nylon film production line in Korea. The main reason is the continued deficit.

According to the industry on the 20th, Hyosung Chemical is currently considering ways to organize domestic nylon film production lines. Hyosung Chemical is currently producing nylon films in Daejeon and Gumi factories and Guangzhou, China. Annual output at home and in China exceeds 12 000 tons.

It is reported that the domestic production line is being discussed to maintain the Chinese plant instead of withdrawing it. A Hyosung official said, "It is right to consider withdrawing the domestic production line, but there is no decision yet, such as withdrawal."

Nylon film is widely used as a packaging material for household goods due to its excellent shock strength and oxygen blocking. Hyosung Chemical entered the nylon film business in 1996. Hyosung Chemical's Nylon Film holds the largest market share in the domestic market.

Behind Hyosung Chemical's consideration of withdrawing its nylon film production line in South Korea is its poor performance. In the aftermath of COVID-19, the front-line business where film and other products are used has been deteriorating for a long time. The production facilities of polypropylene (PP) and propane dehydrogenization (PDH) in Vietnam, which Hyosung Chemical invested $1.28 billion (about KRW 1.6 trillion), were not properly operated for a while due to facility defects.

Hyosung Chemical is in the red for six consecutive quarters from the fourth quarter of 2021 to the first quarter of this year. Stock markets predict Hyosung Chemical will post a deficit (-47.7 billion won) in the second quarter of this year.

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

주요기사

[Exclusive] Samsung Electronics Passes NVIDIA’s HBM3E 12-High Qualification Test, Secures Supply Deal2025.09.19
Civic Groups File Complaint Against Baemin and Coupang Eats Over Alleged Misleading “One-Person Free Delivery” Promotions2025.09.19
KT Confirms Additional Victims in Unauthorized Micro-Payment Case, Faces Criticism Over Initial Response2025.09.19
KFTC Grants Conditional Approval for Joint Venture Between Shinsegae Group and Alibaba Group2025.09.19
Supreme Court Rules in Favor of NTS on U.S. Unregistered Patent Royalties2025.09.19
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사